Chris Ogden
Director of Finance/CFO bij CYTOMX THERAPEUTICS, INC.
Vermogen: 186 795 $ op 31-03-2024
Profiel
Chris Ogden is currently the Chief Financial & Accounting Officer at CytomX Therapeutics, Inc. He previously worked as the Chief Financial Officer-Diabetes Division at Eli Lilly & Co. and as the Chief Financial Officer & Treasurer at Lilly del Caribe, Inc. Mr. Ogden completed his undergraduate degree at Wabash College and holds an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 19-03-2024 | 85 686 ( 0.13% ) | 186 795 $ | 31-03-2024 |
Actieve functies van Chris Ogden
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 21-09-2022 |
Eerdere bekende functies van Chris Ogden
| Bedrijven | Functie | Einde |
|---|---|---|
Lilly del Caribe, Inc.
 Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Director of Finance/CFO | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Opleiding van Chris Ogden
| Wabash College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly del Caribe, Inc. is a Puerto Rican pharmaceutical manufacturing company. The private company is based in Mayagüez, Puerto Rico. | Health Technology |
